|
Publications
|
|
|
|
Court of Appeals Invokes First Amendment to Reverse Conviction of Sales Rep for Off-Label Promotion
December 10, 2012
On December 3, 2012, the United States Court of Appeals for the Second Circuit, in a 2-1 decision, reversed the conviction of a pharmaceutical sales representative for...
more
Supreme Court Hears Argument on Deadline for Medicare Reimbursement Appeals
December 10, 2012
On Tuesday, the U.S. Supreme Court heard oral arguments about whether the 180-day deadline for bringing Medicare reimbursement appeals is fixed or open to equitable...
more
Blowing the Whistle for Tax Dollars and Early Retirement: Views from the Perspectives of Both Whistleblowers and Taxpayers
December 06, 2012
While businesses have for some time been aware of the possibility of "tax whistleblowers" – employees or outside advisors who anonymously...
more
|
view as PDF
Texas Power Plants Obtain TCEQ Ruling Supporting Pollution Control Property Tax Exemption for HRSGs
December 7, 2012
On December 5, 2012, the Texas Commission on Environmental Quality ("TECQ") explicitly affirmed that equipment that avoids polluting emissions solely by...
more
Comment Period Opens for EU Proposed Framework on Medical Device Regulation
December 7, 2012
On November 12, 2012, the UK government, through the Medicines and Healthcare products Regulatory Agency ("MHRA"), launched a consultation on the European...
more
EU Pharmacovigilance: European Commission Launches Public Consultation on Phasing-in of Symbol Identifying Medicines Under Additional Monitoring
December 7, 2012
The European Commission (the "Commission") has opened a public consultation on phasing-in a black symbol identifying medicines which are subject to additional...
more
FDA Suspends First Food Facility Registration
December 6, 2012
On November 26, 2012, the U.S. Food and Drug Administration ("FDA") suspended the food facility registration of Sunland Inc., a New Mexico producer of nuts, and...
more
FDA Issues Draft Guidance for IRBs, Clinical Investigators, and Sponsors
December 6, 2012
On November 20, 2012, the U.S. Food and Drug Administration ("FDA") released a draft guidance , entitled "Guidance for IRBs, Clinical...
more
Court of Appeals Invokes First Amendment to Reverse Conviction of Sales Rep for Off-Label Promotion
December 6, 2012
On Monday, December 3, the United States Court of Appeals for the Second Circuit, in a 2-1 decision, reversed the conviction of a pharmaceutical sales representative for...
more
Hong Kong International Arbitration Centre (HKIAC) Foreign Arbitrators' Forum
December 06, 2012
Fulbright & Jaworski L.L.P. and the HKIAC are pleased to invite you to review the presentation materials from a seminar of a panel including HKIAC's...
more
|
view as PDF
Transparency International Releases the 2012 Corruption Perception Index
December 5, 2012
Companies that operate globally must constantly assess the corruption risks they face in the countries in which they operate. Transparency International, a global...
more
No Privilege for Compliance Logs and Business Audits in Hospital False Claims Case
December 5, 2012
A hospital's compliance matters and business audits aren't protected by the attorney-client privilege just because they're "funneled through an attorney&q...
more
Court Nixes Repeat CID After Dismissal of Whistleblower Complaint
December 5, 2012
A federal court rejected the government's second civil investigative demand ("CID") to a hospital after the court had already dismissed the complaint. The...
more
Fifth Circuit Addresses Standards Associated With Preserving Causes Of Action In Plans of Reorganization and a Debtor’s Standing to Pursue Them
December 4, 2012
One of the most debated intricacies of the reorganization process under the United States Bankruptcy Code in recent years has been the level of detail a debtor must...
more
Fulbright Forum: How to Get The Most From Rule 502(d): Protecting Privilege in the Production of Documents
December 04, 2012
Pages(81):
First ...
<< | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | >>
Last ...
Inadvertent waiver of privilege is one of the most significant concerns of in-house counsel, yet since Federal Rule of Evidence 502 was enacted in 2008,...
more
|
view as PDF
|